Sana Biotechnology Announces Sale of Approximately $69 Million of Shares Through its At-the-Market (ATM) Facility
Sana Biotechnology, Inc. (SANA) Presents at Bank of America Global Healthcare Conference 2026 Transcript
Sana Biotechnology Presents Preclinical Data for In Vivo CAR T Cell Therapy SG293 Surrogate Demonstrating Cell-Specific Delivery, Potent CAR T Cell Generation, and Deep B Cell Depletion in NHPs
Sana Biotechnology Reports First Quarter 2026 Financial Results and Business Updates
Sana Biotechnology to Present at the BofA Securities 2026 Healthcare Conference
Sana Biotechnology Announces Oral Presentation Highlighting Preclinical Data from in vivo CAR T SG293 at the American Society of Gene & Cell Therapy (ASGCT) 2026 Annual Meeting
Brokerages Set Sana Biotechnology, Inc. (NASDAQ:SANA) Target Price at $8.00
Sana Biotechnology, Inc. (SANA) Presents at The Citizens Life Sciences Conference 2026 Transcript
Sana Biotechnology, Inc. (SANA) Presents at TD Cowen 46th Annual Health Care Conference Transcript
Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
Sana Biotechnology to Present at March 2026 Investor Conferences
Genomics Stocks That Deserve a Place in Your Portfolio in 2026
Sana Biotechnology: A Small, Speculative Play
Sana Biotechnology, Inc. (NASDAQ:SANA) Receives Consensus Rating of “Moderate Buy” from Analysts
Sana Biotechnology (SANA) Is Up 5.46% in One Week: What You Should Know
Wall Street Analysts Think Sana (SANA) Could Surge 74.2%: Read This Before Placing a Bet
Sana Biotechnology Stock: Promising T1D Science, But Wait For Dips
Sana Biotechnology, Inc. (SANA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Sana Biotechnology to Present at the 44th Annual J.P. Morgan Healthcare Conference
Sana Biotechnology (NASDAQ:SANA) Trading 7.4% Higher Following Analyst Upgrade
Three Genomics Stocks Worth Tracking This Year
Corient Private Wealth LLC Has $3.10 Million Stock Position in Sana Biotechnology, Inc. $SANA
Sana Biotechnology Announces Publication in Nature Biotechnology of in vivo Gene Editing of Human Hematopoietic Stem Cells in Preclinical Models Using the Fusogen Platform
Sana Biotechnology, Inc. (SANA) Presents at Evercore 8th Annual Healthcare Conference Transcript
Sana Biotechnology, Inc. (SANA) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Sana Biotechnology to Present at December 2025 Investor Conferences
Top 3 Genomics Stocks to Consider for Your Portfolio
All You Need to Know About Sana (SANA) Rating Upgrade to Buy
Sana Biotechnology: Scope Goes Beyond HIP-Modified Pancreatic Islet Cells For T1D
Sana Biotechnology: A Big Winner In Waiting? Maybe, But It Won't Happen Overnight
Sana Biotech Stock — The Next '100-Bagger'?
Sana Biotechnology, Inc. (SANA) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript
Sana Biotechnology, Inc. (SANA) Presents at Wells Fargo 20th Annual Healthcare Conference 2025 Transcript
Sana Biotechnology, Inc. (SANA) Presents At Citi's Biopharma Back To School Conference Transcript
IQVIA and Flagship Pioneering Announce Strategic Collaboration to Accelerate the Development of Breakthrough Life Sciences Companies
Sana Biotechnology to Present at September 2025 Investor Conferences
Sana Biotechnology Announces Closing of Full Exercise of Underwriters' Option to Purchase Additional Shares
Sana Biotechnology: Fundraising Triggers Major Sell-Off, I'm Still Intrigued
Sana Biotechnology Announces Pricing of Public Offering
Sana Biotechnology Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Seres Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates
Sana Biotechnology Announces Publication in New England Journal of Medicine of Groundbreaking Clinical Data from Transplantation Without Immunosuppression of Hypoimmune-Modified, Insulin-Producing Islet Cells in Patient with Type 1 Diabetes
Sana Biotechnology Announces Positive Six-Month Clinical Results from Type 1 Diabetes Study of Islet Cell Transplantation Without Immunosuppression
Sana Biotechnology Announces Invited Oral Presentation at the 85th Annual American Diabetes Association Scientific Sessions
Sana Biotechnology to Present at June 2025 Investor Conferences
Securities Lawsuit Alert: Sana Biotechnology, Inc. (SANA) - Contact Levi & Korsinsky Before May 20, 2025
SANA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sana Biotechnology, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Lost Money on Sana Biotechnology, Inc. (SANA)? Join Class Action Before May 20, 2025 - Contact Levi & Korsinsky
SANA DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Sana Biotechnology, Inc. Investors to Secure Counsel Before Important May 20 Deadline in Securities Class Action - SANA